APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 85 filers reported holding APPLIED MOLECULAR TRANS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,364,185 | -39.2% | 8,689,075 | -0.1% | 0.71% | -37.5% |
| Q2 2023 | $2,243,120 | -37.6% | 8,694,264 | -0.3% | 1.13% | -37.5% |
| Q1 2023 | $3,595,287 | -2.4% | 8,721,447 | -0.5% | 1.81% | -9.9% |
| Q4 2022 | $3,683,056 | -58.3% | 8,769,181 | -3.3% | 2.01% | -53.8% |
| Q3 2022 | $8,825,000 | -66.5% | 9,069,582 | +0.1% | 4.35% | -58.0% |
| Q2 2022 | $26,376,000 | -61.5% | 9,063,746 | -0.4% | 10.35% | -44.6% |
| Q1 2022 | $68,423,000 | -46.1% | 9,098,780 | +0.3% | 18.70% | -17.0% |
| Q4 2021 | $126,875,000 | -45.6% | 9,075,488 | +0.7% | 22.54% | -6.4% |
| Q3 2021 | $233,064,000 | -41.9% | 9,009,055 | +2.8% | 24.09% | -42.5% |
| Q2 2021 | $400,899,000 | +4.7% | 8,764,720 | +0.8% | 41.88% | -2.0% |
| Q1 2021 | $382,793,000 | +43.6% | 8,697,874 | +0.4% | 42.74% | +1.3% |
| Q4 2020 | $266,577,000 | -3.3% | 8,663,547 | +0.0% | 42.20% | +7.0% |
| Q3 2020 | $275,672,000 | +26.8% | 8,663,466 | +0.2% | 39.44% | +7.7% |
| Q2 2020 | $217,401,000 | – | 8,647,640 | – | 36.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ Capital Group, LLC | 9,075,488 | $126,875,000 | 22.54% |
| Founders Fund VI Management, LLC | 826,607 | $11,555,000 | 18.03% |
| Founders Fund V Management, LLC | 3,611,615 | $50,409,000 | 2.67% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 290,000 | $4,054,000 | 0.34% |
| Pinz Capital Management, LP | 42,800 | $598,000 | 0.23% |
| EcoR1 Capital, LLC | 400,000 | $5,592,000 | 0.18% |
| Burleson & Company, LLC | 87,462 | $1,223,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 64,153 | $897,000 | 0.11% |
| Virtus ETF Advisers LLC | 12,313 | $172,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 27,853 | $389,000 | 0.03% |